Injured by Testosterone?  Call One of Our Testosterone Attorneys in Florida.

Men who have low testosterone, and even men who merely show signs of having low testosterone, are the primary target group for several pharmaceutical companies whose main focus is testosterone replacement. Millions of dollars get spent each year on marketing alone, in order to appeal to male consumers who may have low testosterone which is also loosely described as having “Low T.” For those who do opt to receive a form of treatment, the options for therapy are seemingly endless.

Not every man who is experiencing “Low T” wants to take a daily pill, and an even smaller group would like to receive injections. For these reasons, other forms of treatment have been created in gel and patch form. Signs that you or someone you know has low testosterone could include fatigue, decreased libido, having trouble remembering, and impotence. In order to treat this condition, the FDA conferred approval for testosterone replacement therapy. However, it has recently been discovered that there is a link between testosterone replacement therapy and heart attacks. Just last year the Journal of the American Medical Association men age 60 or older who were in some form of testosterone replacement therapy were 30 percent more likely to have a stroke, heart attack, or die, as opposed to men in the same age group who were not undergoing testosterone replacement therapy. Stroke, heart attack, deep vein thrombosis, and worst of all death, are just some of the side effects of testosterone replacement therapy.

If you have taken any of the following drugs you may be at risk:

This year the FDA released a statement letting the public know that they will conduct further research regarding the link between “Low T” treatments and the adverse side effects.

If you have experienced any of the adverse effects of “Low T” treatments you may be entitled to compensation.  Contact our attorneys handling testosterone lawsuits at Zimmerman & Frachtman today for a free case review.